Emmanouil Brilakis, MD
Interventional Cardiology · Minneapolis, MNNPI 1194781674
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 33.2% of the total. Among interventional cardiology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 484 payments — averaging $1131.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$182K
- Abbott$162K
- Cardiovascular Systems Inc.$57K
- Boston Scientific$41K
- GE HealthCare$26K
- Teleflex LLC$16K
- plus $64K from 23 others
Across 82 payments — averaging $20,279 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$701K
- GE HealthCare$529K
- Boston Scientific$181K
- Amgen$65K
- Arrow International, Inc.$49K
- Siemens Medical Solutions USA, Inc.$44K
- plus $94K from 5 others
What the payments were for
- Consulting fees$264,63948%
- Speaking & faculty fees$235,24643%
- Travel & lodging$29,9915%
- Food & beverage$17,6293%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 157 | $181,655 |
| Abbott | 144 | $161,649 |
| Cardiovascular Systems Inc. | 38 | $56,745 |
| Boston Scientific | 40 | $41,296 |
| GE HealthCare | 19 | $25,939 |
| Teleflex LLC | 15 | $16,075 |
| Amgen | 9 | $12,683 |
| Biotronik Inc. | 6 | $8,591 |
| Opsens Inc. | 5 | $7,932 |
| Cordis US CORP. | 6 | $7,296 |
| Siemens Medical Solutions USA, Inc. | 3 | $7,148 |
| Recor Medical Inc | 6 | $4,348 |
| Vascular Solutions, Inc. | 1 | $2,475 |
| Asahi Intecc USA, Inc. | 4 | $2,344 |
| Magenta Medical Inc | 4 | $2,250 |
| Arrow Interventional, Inc. | 1 | $2,250 |
| Terumo Medical Corporation | 3 | $2,150 |
| Cardiva Medical, Inc. | 1 | $1,500 |
| Arrow International, Inc. | 1 | $900 |
| Heartflow, Inc. | 4 | $863 |
| Abiomed | 6 | $568 |
| Shockwave Medical, Inc | 2 | $232 |
| Reflow Medical Inc | 1 | $177 |
| Cleerly, Inc. | 2 | $129 |
| Philips North America LLC | 1 | $119 |
| Biolife, L.L.C. | 1 | $110 |
| Getinge USA Sales, LLC | 1 | $51 |
| Cathworks, Inc. | 1 | $29 |
| Chiesi USA, Inc. | 2 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$99,107
- ONYX FRONTIER$53,756
- Resolute$47,875
- Xience V coronary stent system$41,053
- Diamondback Coronary$29,220
- Coronary Orbital Atherectomy System$28,828
- GENERAL VASCULAR ACCESS$23,480
- VISIPAQUE$13,750
- RESOLUTE ONYX$12,758
- DRAGONFLY OPSTAR$12,205
- SYMPLICITY G3$11,944
- Repatha$11,485
- GUIDELINER$9,575
- GENERAL - THERAPIES$8,452
- cardio$6,536
- SavvyWire$6,300
- Diamondback Peripheral$6,210
- Interventional Products$4,725
- Paradise Ultrasound Renal Denervation System$4,315
- GUIDELINER V3 CATHETER$4,050
How this compares
$547,529 in reported general payments places this provider in the 95th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 68 | $94,362 |
| Repatha SureclickEvolocumab | 38 | $31,062 |
| OzempicSemaglutide | 14 | $13,338 |
| XareltoRivaroxaban | 13 | $11,290 |
| ClopidogrelClopidogrel Bisulfate | 133 | $2,250 |
| Ranolazine ErRanolazine | 13 | $2,112 |
| Metoprolol Succinate | 84 | $2,084 |
| Atorvastatin Calcium | 102 | $1,974 |
| Rosuvastatin Calcium | 80 | $1,451 |
| Losartan Potassium | 94 | $1,447 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 57 | $1,165 |
| Amlodipine Besylate | 93 | $964 |
| Ezetimibe | 51 | $688 |
| Carvedilol | 66 | $625 |
| Prasugrel Hcl | 22 | $572 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Minneapolis
- Wesley PedersenMinneapolis$493K
- Michael ManolesMinneapolis$201K
- Jay TraverseMinneapolis$198K
- Robert WilsonMinneapolis$176K
- Yale WangMinneapolis$168K
- Steven RohMinneapolis$67K
- Stefan BertogMinneapolis$64K
- Konstantinos VoudrisMinneapolis$46K
- Michael MooneyMinneapolis$25K
- Alok SharmaMinneapolis$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.